Regulatory news

Contact investor relations

Institutional investors

Please contact David Bishop or Reece de Gruchy, our Investor Relations team by email at investor.relations@croda.com.

Individual investors

Our registrars, Link Asset Services, are here to help with queries from individual investors. Please contact them directly on +44 (0)371 664 0300 (calls are charged at the standard geographic rate and will vary by provider).

You can also sign up to the Registrar's website - www.signalshares.com - you will need your investor code to do this and once registered you will be able to check your shareholding, view your dividend history, elect for the dividend reinvestment plan, register a change of address and update dividend mandate instructions.

Mailing list

If you would like to receive investor relations information via email please provide your details below.

Please provide your first name
Please provide your last name
Email is not valid
Please select your country

Interest

Please select at least one
We need your consent
Please tick reCaptcha.

Read more

Matrixyl Neolide image of lady showing how ingredient impacts skin in a positive way

Croda unveils Matrixyl® Neolide™, an iconic peptide with smarter delivery

Croda introduces Matrixyl® Neolide™, an iconic peptide with smarter delivery, designed to maximise performance and unlock new possibilities in advanced skin care.
Erik Jan Bartels, Regional President of Croda Life Sciences, explains the benefits of seed coating

ISF World Seed Congress 2026 in Lisbon

6 May 2026: Incotec is sponsor of the ISF golf tournament and actively participates in the congress program. Our team are present to exchange views on shared challenges and future needs.
Marta Dobrowolska, Head of Data Science and Knowledge Management, Incotec

OPINION: Why generative AI can be very convincing when it is wrong

19 May 2026: Learn why generative AI hallucinations sound accurate, the risks, and practical ways to verify AI-generated content.